Business Standard

Dipna Pharmachem Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 12Th June 2024 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors ...Read More10/06/2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th May 2024 Outcome of Board Meeting held on 6th May 202406/05/2024
Board Meeting Intimation for Re-Schedule Of Board Meeting Held Today I.E. 2Nd May 2024 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors ...Read More02/05/2024
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Statement on Deviation or Variation of funds under Regulation 32 of SEBI (LODR) ...Read More01/05/2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2024 Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations 2015.27/04/2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2024 Submission of Certificate under Regulation 40(9) read with Regulation 40(10) of ...Read More26/04/2024
Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 26Th April 2024 To 2Nd May 2024 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors ...Read More25/04/2024
Update on board meeting Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors ...Read More22/04/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More18/04/2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substan...Read More18/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Submission of Certificate under Regulation 74(5) of SEBI (Depository and Partici...Read More13/04/2024
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors ...Read More08/04/2024
Intimation Of Trading Approval Received For Rights Issue Of Fully Paid-Up Equity Shares ByDipna Pharmachem Limited(The Company) Under Regulation 30 Of The Securities And ExchangeBoard Of India (Listing Obligation And Disclosure Requirements) Regulatio Intimation of Trading Approval for Rights Issue06/04/2024

Load more